000			02600 am a22002653u 4500
042			_adc
100	1	0	_aSahlin, Daniel _eauthor _91037
700	1	0	_aRezanezad, Babak _eauthor _91038
700	1	0	_aEdvinsson, Marie-Louise _eauthor _91039
700	1	0	_aBachus, Erasums _eauthor _91040
700	1	0	_aMelander, Olle _eauthor _91041
700	1	0	_aGerward, Sofia _eauthor _91042
245	0	0	_aSelf-care Management Intervention in Heart Failure (SMART-HF): A Multicenter Randomized Controlled Trial
260			_c2022-01-01.
500			_a/pmc/articles/PMC7612444/
500			_a/pubmed/34161807
520			_aBACKGROUND: Self-care behavior is important in avoiding hospitalization for patients with heart failure (HF) and refers to those activities performed with the intention of improving or restoring health and well-being, as well as treating or preventing disease. The purpose was to study the effects of a home-based mobile device on self-care behavior and hospitalizations in a representative HF-population. METHODS AND RESULTS: SMART-HF is a randomized controlled multicenter clinical trial, where patients were randomized 1:1 to receive standard care (control group [CG]) or intervention with a home-based tool designed to enhance self-care behavior (intervention group [IG]) and followed for 240 days. The tool educates the patient about HF, monitors objective and subjective symptoms and adjusts loop diuretics. The primary outcome is self-care as measured by the European Heart Failure Self-care behavior scale and the secondary outcome is HF related inhospital days. A total of 124 patients were recruited and 118 were included in the analyses (CG: n = 60, IG: n = 58). The mean age was 79 years, 39% were female, and 45% had an ejection fraction of less than 40%. Self-care was significantly improved in the IG compared to the CG (median (interquartile range) (21.5 [13.25; 28] vs 26 [18; 29.75], p = 0.014). Patients in the IG spent significantly less time in the hospital admitted for HF (2.2 days less, relative risk 0.48, 95% confidence interval 0.32-0.74, P = .001). CONCLUSIONS: The device significantly improved self-care behavior and reduced in-hospital days in a relevant HF population. (J Cardiac Fail 2022;28:3-12)
540			_a
540			_ahttps://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/)
546			_aen
690			_aArticle
655	7		_aText _2local
786	0		_nJ Card Fail
856	4	1	_uhttp://dx.doi.org/10.1016/j.cardfail.2021.06.009 _zConnect to this object online.
999			_c1530 _d1530